AI assistant
HCA Healthcare, Inc. — Director's Dealing 2022
May 2, 2022
29867_dirs_2022-05-02_8972646f-a98d-4174-971c-a95ac56abcbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HCA Healthcare, Inc. (HCA)
CIK: 0000860730
Period of Report: 2022-04-28
Reporting Person: Smith Andrea B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-28 | Common Stock | P | 1160 | $213.6339 | Acquired | 2239 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 82 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $213.23 to $213.73, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: The shares reported herein are held in fully managed accounts over which the reporting person does not have any investment authority. The reporting person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein.